MedTrace Logo

Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia

NCT04185428 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-04-07

No results posted yet for this study

Summary

This pilot study will use a mixed methods approach to evaluate the feasibility and acceptability of Integrative Therapies, a bedside service offering mindfulness-based interventions (still meditation, meditative movement, relaxation techniques, and massage therapy) as non-pharmacologic treatment for symptom management in newly diagnosed adult Acute Myeloid Leukemia (AML) patients undergoing induction chemotherapy

Conditions

Interventions

BEHAVIORAL

Integrative Therapy

still meditation, meditative movement, relaxation techniques, and massage therapy

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Nosha Farhadfar, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-09
Primary Completion
2025-03-04
Completion
2025-03-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185428 on ClinicalTrials.gov